CST3 and chronic kidney disease: Therefore, the integration of serum cystatin C into clinical practice, especially as an adjunctive test in high-risk populations such as diabetics and hypertensives, can significantly enhance the early diagnosis and monitoring of CKD, ultimately enabling timely interventions to slow disease progression and improve patient outcomes.